跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,828 条关于
“KRAS-G12R”
全部
1,828
临床试验
1,152
药物
240
机构
1
资讯
435
去年
KRAS Mutation Subtypes Linked to Varying Outcomes in Pancreatic Cancer
2年前
Elicio's ELI-002 Cancer Vaccine Shows Promising Results in Phase 1 Trial for Pancreatic and Colorectal Cancer
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
2年前
Revolution Medicines' RAS(ON) Inhibitors Show Promise in Lung and Pancreatic Cancers
去年
Elicio Therapeutics Completes Enrollment in Phase 2 Trial of ELI-002 for mKRAS-Driven Pancreatic Cancer
上个月
KRAS G12C: From 'Undruggable' to Druggable with Sotorasib and Adagrasib
6个月前
Silexion Therapeutics Receives Israeli Regulatory Approval for Phase 2/3 Trial of KRAS-Targeting RNAi Therapy SIL204
去年
Silexion Therapeutics Partners with AMS for Phase 2/3 Trials of KRAS-Targeting siRNA Therapy SIL204
7个月前
HOOKIPA Pharma Sells Oncology Assets Including HPV and KRAS-Targeted Therapies to NeoTrail Therapeutics
去年
Cancer Vaccines Emerge as Promising Frontier in Oncology with Multiple Approaches Showing Clinical Success
第 1 页,共 44 页
上一页
下一页